Entasis Therapeutics
Discovery and development of anti-infective products.
Launch date
Employees
Market cap
-
Enterprise valuation
$196m (Public information from Sep 2018)
Waltham Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $40.0m | Series A | |
$50.0m | Series B | ||
$6.3m | Grant | ||
* | $31.9m | Series B | |
| N/A | $75.0m Valuation: $196m | IPO | |
| N/A | $35.0m | Post IPO Equity | |
$7.5m | Private Placement VC | ||
* | N/A | Acquisition | |
| Total Funding | $136m | ||
Related Content
Recent News about Entasis Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.